C-Reactive Protein Test (CRP) Market Size is USD 832.89 Million in 2026

The global C-reactive protein (CRP) test market, valued at USD 785 million in 2025, is projected to reach approximately USD 1.42 billion by 2035, growing at a robust CAGR of 6.10%. This growth reflects increasing demand for CRP testing in diagnosing inflammation-related conditions globally.

C-Reactive Protein Test (CRP) Market Statical Scope

Market Overview

What is the C-Reactive Protein Test (CRP)?

The C-reactive protein (CRP) test market is focused on diagnostic tests that measure CRP levels in blood to detect inflammation and monitor disease progression. The rising prevalence of chronic conditions such as cardiovascular diseases, infections, and autoimmune disorders is driving market growth.

C-Reactive Protein Test (CRP) Market, By Region

• North America: Dominates the market due to advanced healthcare infrastructure, high adoption of diagnostic technologies, and increased prevalence of chronic inflammatory dise
• Asia-Pacific: Growing rapidly due to rising healthcare awareness, expanding healthcare infrastructure, and increasing incidence of chronic conditions, particularly in emerging economies like China and India.
• Europe: Steady market growth driven by strong healthcare systems, widespread adoption of CRP tests, and increasing focus on preventive healthcare and chronic disease management.
• Latin America: The market is expanding as healthcare access improves and there is increasing recognition of the importance of early inflammation detection in managing chronic diseases.

Segment Insights

C-Reactive Protein Test (CRP) Market, By Type

• ELISA: Measures CRP levels using an enzyme-linked immunosorbent assay for highly sensitive and specific detection.
• Immunoturbidimetric: Detects CRP by measuring changes in light absorption caused by antigen-antibody complexes in blood samples.
• CLIA: Uses chemiluminescence immunoassay technology to provide rapid and accurate CRP quantification.
• Others: Includes alternative methods for CRP measurement, such as nephelometry and point-of-care testing devices.

C-Reactive Protein Test (CRP) Market, By Application

• Hospitals: Use CRP tests for rapid diagnosis, monitoring of inflammation, and management of chronic and acute diseases in patients.
• Diagnostic Laboratories: Conduct CRP testing to provide accurate inflammation assessments and support clinical decision-making for healthcare providers.
• Others: Include clinics, research institutions, and point-of-care settings that utilize CRP tests for disease monitoring.

C-Reactive Protein Test (CRP) Market Share, By Region, 2025 (%)

• North America (40%) — The leading region in CRP test adoption due to advanced healthcare infrastructure and widespread diagnostic technology use.
• Europe (30%) — A key market with strong regulatory standards and high CRP test usage in hospitals and diagnostic centers.
• Asia Pacific (25%) — Growing region in CRP test adoption, driven by increasing healthcare investments and rising awareness of inflammatory diseases.
• LAMEA (5%) — A smaller market with limited access and adoption of CRP testing, concentrated in specific urban areas.

C-Reactive Protein Test (CRP) Market Share, By Type, 2025 (%)

• ELISA (28%) — A laboratory technique used to detect and quantify CRP levels using enzyme-linked immunosorbent assay, commonly used for research and diagnostics.
• Immunoturbidimetric (31%) — A method that measures the concentration of CRP by assessing the change in light transmission as it reacts with antibodies in the test sample.
• CLIA (35%) — Chemiluminescence immunoassay, a highly sensitive testing method that uses light emission to detect CRP levels in clinical diagnostics.
• Others (6%) — Other CRP testing methods and technologies that are less commonly used compared to ELISA, Immunoturbidimetric, and CLIA.

C-Reactive Protein Test (CRP) Market Share, By Application, 2025 (%)

• Hospitals (50%) — Healthcare institutions primarily using CRP tests for patient diagnosis, monitoring inflammation, and assessing disease progression.
• Diagnostic Laboratories (40%) — Specialized labs performing CRP tests for diagnosing and monitoring various inflammatory conditions and diseases.
• Others (10%) — Other applications including research institutions, clinics, and health monitoring centers utilizing CRP tests for various purposes.